ReMedium Plus - Fine
 

Description

ReMedium completed its clinical trials on March 2009(Seoul National University Hospital) and export approvals were obtained. It is a subtle product that has 5 year clinical experience in Japan where safety and longevity has been verified.

Increase long lasting effect in the human body by creating pearl shaped beads to overcome the fast dissolution through natural hyaluronidase of conventional reticulate structured HA.

ReMedium Plus - Fine  

• HA Concentration - 20mg/ml
• Volume - 1ml X 1cc
• Needle - 30G 13mm UTW Needle (Ultra Thin Wall)
• Area used - Mid Dermis Fine Wrinkle
• Cross linking rate 50%